Rosa’s Derek Bartlett to Present Work on Mechanistic Modeling in Diabetes Drug Design at the AAPS Conference
Dr. Bartlett will discuss the use of modeling to evaluate combination therapies for diabetes, November 13th, 2013 in San Antonio, Texas. - November 13, 2013
Rosa & Co CEO, Dr. Ron Beaver Presents "Systems Pharmacology: First Principles to Effective Practice" in the Plenary Session of the Integrating Pharmacometrics Summit
Rosa & Co. LLC, a drug development advisory firm with expertise in drug-disease modeling and simulation, announced that Dr. Ron Beaver, CEO, presented a plenary session talk at the Hanson Wade Integrating Pharmacometrics Summit (October 21st -23rd 2013), Munich, Germany, entitled... - November 13, 2013
Rosa’s Toufigh Gordi to Present Models and Their Utility in Drug Development at Target Meeting’s 3rd World Drug Discovery Online Conference
Dr. Toufigh Gordi will discuss the application of modeling at different stages in the drug development process, October 16th, 2013. - October 08, 2013
Dr. Dean Bottino, Roche, to Discuss Multi-Scale Modeling in Development of Cancer Drugs in Rosa’s Impact Webinar Series
Dr. Bottino will present the Webinar “Multi-scale modeling to optimize the antitumor effect of antibody-dependent cell-mediated cytotoxicity (ADCC) enhanced therapies” on June 19, 2013. - May 28, 2013
Dr. Toufigh Gordi to Discuss the Selection of Appropriate Mathematical Modeling Techniques in Drug Development at 4th World PK/PD Summit
Dr. Gordi, will discuss choice of models and their Impact in the Drug Development Process on November 28, 2012 in Frankfort, Germany. - November 08, 2012
Dr. Pratap Singh, to Discuss PK/PD Modeling Analysis of a Compound Targeting Muscle Growth in Rosa’s Impact Webinar Series
Dr. Singh, will present “Role of Myostatin in Muscle Growth: Key Learnings From PK/PD Modeling Analysis” Webinar October 17, 2012. - October 10, 2012
Dr. Malcolm Rowland, to Discuss Physiologically-Based Pharmacokinetics in Rosa’s Impact Webinar Series
Dr. Rowland, will present “Drug development and physiologically based pharmacokinetics” Webinar September 19, 2012. - September 08, 2012
GlaxoSmithKline and Rosa Present Psoriasis Collaboration Results at 17th International IRA Conference
PhysioPD™ modeling collaboration in psoriasis to be presented September 9-13, 2012. - August 14, 2012
Rosa to Present Mechanistic Systems Pharmacology Workshop at 2012 ICSB Conference
Workshop focused on Rosa’s Model Qualification Method to be held August 19th, Toronto, Canada. - August 02, 2012
Dr. Scott Siler to Discuss DILIsym Model in Rosa’s World-Wide Webinar Series, “Impact of Modeling & Simulation in Drug Development”
Dr. Siler, will present “The DILIsym™ model and its application to hepatotoxicity testing in drug development” Webinar June 19, 2012. - June 12, 2012
Rosa to Present Beta Cell Mass Research at 2012 ADA Annual Meeting
Modeling analysis enables development of clinical markers for beta cell mass. - June 02, 2012
Dr. Toufigh Gordi to Discuss Pediatric PK Model in Rosa’s World-Wide Webinar Series, “Impact of Modeling & Simulation in Drug Development”
Dr. Gordi, will present “Mechanistic PK/PD Modeling in Pediatrics” Webinar May 22, 2012. - May 18, 2012
Dr. Birgit Schoeberl to Discuss Using Mathematical Models to Set Design Criteria for Antibody-Based Therapies in Rosa’s "Impact" World-Wide Webinar Series
Dr. Schoeberl will present “Using Mathematical Models To Set Design Criteria For Antibody-Based Therapies” April 17, 2012. - April 04, 2012
Rosa to Present Two Lectures at the European Foundation of Medicinal Chemists Conference
Rosa to Present The MQM Standard and Lead Optimization Using Systems Pharmacology Modeling - April 01, 2012
Rosa to Present Systems Pharmacology Workshop at 3rd Annual World PK/PD Summit
Rosa Workshop Presents the MQM Quality Standard for Mechanistic Modeling - March 26, 2012
Rosa to Present at 2012 Keystone Symposia: Advances in Islet Biology
Modeling analysis enables development of biomarkers for beta cell mass. - March 24, 2012
Dr. Joga Gobburu to Discuss the Impact of Pharmacometrics on Drug Approvals in Rosa’s World-Wide Webinar Series, “Impact of Modeling & Simulation in Drug Development”
Dr. Gobburu will present “Impact of Pharmacometric Analyses on New Drug Approval and Labelling Decisions” March 20, 2012. - March 16, 2012
Rosa PK/PD Collaboration with Pfizer to be Presented at ASCPT 2012
PK/PD analyses used to support the rationale for therapeutic strategies targeting myostatin pathway. - March 10, 2012
Rosa Announces Publication of Its PhysioPD™ Model Qualification Method and Series of Educational Events
Series of Seminars and Workshops to be held in 2012 across the US and in Europe. - March 01, 2012
Biopontis Alliance Fund and Rosa Announce Strategic Relationship for Early Stage Drug Development
Collaboration will combine Rosa’s PhysioPD™ modeling & simulation capabilities with Biopontis’ innovative asset sourcing and financial structure to improve early drug development productivity. - February 07, 2012
Dr. Hartmut Derendorf to Discuss PK/PD-based Drug Development in Rosa’s World-Wide Webinar Series, “Impact of Modeling & Simulation in Drug Development”
Dr. Derendorf, will present “PK/PD-based Development of Anti-infective Agents” February 13, 2012. - February 06, 2012
Rosa to Present at 2012 Keystone Symposia: Cancer and Metabolism
Modeling analysis enables understanding efficacy of large numbers of potential drug combinations. - February 03, 2012
Dr. Mike Reed to Participate in Roundtable Panel of American Society of Phamacometrics
Industry Presenters Will Focus on the Use and Benefits of Physiologic, Mechanistic Models in Drug Development - January 30, 2012
Pfizer and Rosa to Present at 2012 Keystone Symposia: Pathogenesis of Diabetes
Insulin degradation and the mechanisms controlling it have significant impact on glucose homeostasis and diabetes. - January 26, 2012
Rosa’s Toufigh Gordi to Present at 2nd Annual Pediatric Pharmacology Conference 2012
Integration of PK/PD and mechanistic physiological models improves drug development in infants. - January 24, 2012
Rosa to Provide Noncompartmental Pharmacokinetic Analyses NCAs for Advanced Research Institute
Integration Creates Seamless Data Management and Analysis Capability for ARA Customers - November 14, 2011
Dr. Mike Reed Joins Rosa & Co. Executive Management Team
Rosa & Co. LLC, a drug development advisory firm with expertise in drug-disease modeling and simulation, today announced the appointment of Mike Reed as Vice President. - November 01, 2011
Dr. Rebecca Baillie to Present in Rosa’s World-Wide Webinar Series, "Impact of Modeling & Simulation in Drug Development"
Dr. Rebecca Baillie, will present a webinar in Rosa’s monthly public webinar series “How to build a PhysioPD model” on June 20, 2011 at 1:00 pm EDT (GMT -5:00). - June 09, 2011
Rosa Announces Qualification of a Novel Methodology for Prediction of Pediatric Clinical Pharmacology Data in Bile Acid Metabolism
A PhysioPD™ model of bile acid metabolism has incorporated ‘omics data to predict ursodiol clinical data and explain inter-individual variability. - April 28, 2011
Rosa Diabetes PhysioPD™ Collaboration with Pfizer to be Presented at World PK/PD Summit
Diabetes PhysioPD model used to predict long-term clinical outcomes and select doses using only summary pharmacokinetic data from a competitor’s short-term Phase I clinical trial - April 23, 2011
Head of the US FDA Division of Pharmacometrics to Kick-off Rosa’s World-Wide Webinar Series, “Impact of Modeling & Simulation in Drug Development”
You are invited to attend Dr. Goburru’s webinar The “Learn & Apply” Paradigm in Drug Development on April 18, 2011 at 1:00 pm EST (GMT -5:00) (www.rosaandco.com/webinar). This talk will summarize the state of the art in applying drug-disease-trial modeling to decision-making processes in drug development. - April 08, 2011
Rosa Announces Six Poster Presentations at the American College on Pharmacometrics 2011
In collaboration with its clients, Lithera, MediciNova, Pfizer, Vitalea, Rosa & Co will present six posters at the 2011 American College on Pharmacometrics in San Diego, CA on April 4, 2011. The posters describe the use of drug-disease modeling in pharmaceutical development. - March 22, 2011
Rosa & Co. Announces the Appointment of Sharan A. Pagano as Vice President, Scientific Alliances, and the Opening of Rosa’s Boston-Area Office
Rosa & Co. LLC, a drug development advisory firm with expertise in drug-disease modeling and simulation, today announced the appointment of Sharan A. Pagano, Vice President, Scientific Alliances, responsible for worldwide sales and account development, and the opening of Rosa’s new Boston, MA-area office. - March 09, 2011
Rosa & Co and Vitalea Science to Present at ASPCT 2011 Meeting
In collaboration with Vitalea Science, Inc., Rosa & Co will present a poster at the 2011 American Society for Clinical Pharmacology and Therapeutics in Dallas, TX entitled "Compartmental Analysis of Urosodiol PK in Neonates using AMS " at 8:00 am on March 4, 2011. - February 16, 2011